Last quarter (Q ), Prometheus Biosciences's total revenue was $1.10M, a decrease of -71.80% from the same quarter last year. In Q, Prometheus Biosciences's net income was $-40.68M. See Prometheus Biosciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 4.00M	$ 6.81M	$ 3.13M	$ 1.23M	$ 1.12M
Cost of Revenue	-	-	-	-	-
Gross Profit	$ 1.76M	$ 6.81M	-	-	-
Operating Expense	$ 82.41M	$ -152.59M	$ 90.93M	$ 30.24M	$ 17.09M
Operating Income	$ -162.39M	$ -145.78M	$ -87.80M	$ -29.01M	$ -15.97M
Net Non Operating Interest Income Expense	$ 11.82M	$ 4.03M	$ -753.00K	$ -2.12M	$ -761.00K
Other Income Expense	$ 3.70M	$ 429.00K	$ -1.64M	$ -15.00K	-
Pretax Income	$ -150.34M	$ -142.18M	$ -90.19M	$ -31.14M	$ -16.73M
Tax Provision	-	-	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-	-	-
Net Income Common Stockholders	$ -150.34M	$ -142.18M	$ -90.19M	$ -37.14M	$ -29.72M
Basic EPS	$ -4.35	$ -3.49	$ -2.88	$ -1.38	$ -1.10
Diluted EPS	$ -3.53	$ -3.49	$ -2.88	$ -1.38	$ -1.10
Basic Average Shares	$ 168.54M	$ 40.62M	$ 31.33M	$ 26.98M	$ 26.98M
Diluted Average Shares	$ 168.54M	$ 40.62M	$ 31.33M	$ 34.61M	$ 26.98M
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 82.41M	$ -152.59M	$ 90.93M	$ 30.24M	$ 17.09M
Net Income From Continuing And Discontinued Operation	$ -150.54M	$ -142.18M	$ -90.19M	$ -37.14M	$ -29.72M
Normalized Income	$ -70.92M	-	$ -89.54M	$ -31.12M	$ -16.73M
Interest Expense	-	-	$ 861.00K	$ 2.13M	$ 770.00K
EBIT	$ -160.74M	$ -146.21M	$ -89.33M	$ -29.01M	$ -15.96M
EBITDA	$ -113.33M	$ -148.26M	$ -89.08M	$ -28.90M	$ -15.92M

Currency in USD

Prometheus Biosciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing